Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States over the next ...

Roche has pledged to build a giant weight-loss drug factory in the US as part of a $50bn (£37bn) pledge aimed at heading off ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...

Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, ...

Roche has said it will spend $50bn on manufacturing and research and development in the US, becoming the latest pharmaceutical company to promise greater investment in the face of potential tariffs on ...

It joins a growing number of multinational drug companies to announce investments in the US. Read more at straitstimes.com.

The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...

Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...

Trump's looming tariff threats have prompted several announcements, even as the EU pleads for more investment in Europe.